anti-semaglutide antibodies (GLP-1 analogue) Antibody (SAb2274)_AntibodySystem Engineering of a GLP-1 analogue

Blood 132 , 14731477 (2018)

This weight loss contributes to a decreased likelihood of developing cancer, diabetes, and heart disease among individuals who are overweight or obese

For example: poor sleep dehydration high stress poor nutrition These factors affect how the body responds to antioxidant support

Any changes to Ozempic dosing or switching to alternative treatments must be clinician-led with appropriate monitoring of glycaemic control

Factors like age, activity level, and thyroid function all influence metabolism

Researchers suggested this reflected the multifactorial impact of surgery on metabolic and cardiovascular risk